HC Wainwright & Co. Maintains Buy on Evotec, Raises Price Target to $14
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Douglas Tsao maintains a 'Buy' rating on Evotec (NASDAQ:EVO) and raises the price target from $12 to $14.
August 31, 2023 | 10:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evotec's price target has been raised from $12 to $14 by HC Wainwright & Co., maintaining a 'Buy' rating.
The raised price target indicates the analyst's increased confidence in the company's performance. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100